Resource Centers
Special Collections
Urology CME
- Optimal Management of Localized Renal Cell Carcinoma: Surgery, Ablation, or Active Surveillance
- Cases From AHRQ WebM&M: EMR Entry Error -- Not So Benign
- Contemporary Imaging of Incidentally Discovered Adrenal Masses
- Management of Duplex System Ureteroceles in Neonates and Infants
- Diagnosis and Management of Interstitial Cystitis: Issues, Challenges, and Opportunities
- Painless Bloody Urination in a 60-Year Old Woman
- Current Management of Emphysematous Pyelonephritis
- Considerations in the Role of Male Circumcision in the Prevention of HIV Transmission in the USA
- Dealing with the "Disruptive" Physician Colleague
- Imaging Techniques for Prostate Cancer: Implications for Focal Therapy
- The Use of Selective Estrogen Receptor Modulators in Treating Side Effects of Androgen-Deprivation Therapy
- Circumcision May Reduce Incidence of HIV, HSV-2, HPV Infection
- Clinical Assessment of the Crying Infant Should Guide Decision Making
- Bladder Cancer in the Elderly: Clinical Outcomes, Basic Mechanisms, and Future Research Direction
- Lower Abdominal Pain in a 30-Year-Old Woman
- Androgen Deprivation Therapy: Progress in Understanding Mechanisms of Resistance and Optimizing Androgen Depletion
- A 9-Year-Old Boy With a Recurrent Urinary Tract Infection and Failure to Thrive
- HPV in Males: A Review of Disease Burden and Emerging Strategies for Prevention
- Carcinoma in Situ of the Urinary Bladder: Review of Clinicopathologic Characteristics With an Emphasis on Aspects Related to Molecular Diagnostic Techniques and Prognosis
- Photodynamic Therapy for Prostate Cancer -- A Review of Current Status and Future Promise
News CME
- Lower Urinary Tract Symptoms in Elderly Men Increase Risk of Falls
- Enalapril, Losartan May Have Retinal, but Not Renal, Benefits in Type 1 Diabetes
- New Hemoglobin Target Levels in Chronic Kidney Disease Suggested
- FDA Safety Changes: Prevpac, Arava, Treanda
- Lower Urinary Tract Symptoms Associated With Metabolic Syndrome
Medical Education Content
- Dipeptidyl Peptidase-4 Inhibitors in Renal Dysfunction
- Obama vs McCain: Impact on HHS and the FDA in the Next Administration
- Why Should I Report an Adverse Drug Event?
- New Therapeutic Options for Metastatic Castration-Resistant Prostate Cancer: The Latest Data From ASCO 2008
- Evolving Role of mTOR Inhibition in the Treatment of Renal Cell Carcinoma: An Expert Interview With Dr. Robert Motzer
Advisory Board
- Mark P. Cain, MD
- David Ginsberg, MD
- Wayne J. G. Hellstrom, MD, FACS
- David F. Penson, MD
- Marshall Stoller, MD
Scientific Director
Policies and Requirements